LOW-DOSE CYCLOSPORINE A (1, 2 OR 3 MG/KG/DAY) IN A LARGE SERIES OF MODERATE PSORIASIS PATIENTS - PRELIMINARY-RESULTS

被引:0
|
作者
DERIE, MA
TEGELBERG, MJAM
MEINARDI, MMHM
FABER, WR
WITKAMP, L
BOS, JD
VANVLOTEN, WA
机构
[1] UNIV AMSTERDAM,ACAD MED CTR,DEPT DERMATOL,1105 AZ AMSTERDAM,NETHERLANDS
[2] STATE UNIV UTRECHT HOSP,DEPT DERMATOL,3511 GV UTRECHT,NETHERLANDS
[3] SANDOZ LTD,DEPT DERMATOL,UDEN,NETHERLANDS
关键词
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
引用
收藏
页码:307 / 307
页数:1
相关论文
共 50 条
  • [21] Efficacy and prognosis of short term and very low-dose IVIG therapy (200 mg kg-1 day-1) for newly diagnosed acute immune thrombocytopenic purpura in children
    Lee, K. S.
    Kim, J. E.
    Kim, U. H.
    Shim, Y-J
    Kim, J. Y.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2015, 13 : 609 - 610
  • [22] HIGH-DOSE HUMAN-LEUKOCYTE INTERFERON GIVEN AS A 5 DAY CONTINUOUS INTRAVENOUS-INFUSION FOLLOWED BY LOW-DOSE INTRAMUSCULAR MAINTENANCE TREATMENT IN PREVIOUSLY UNTREATED PATIENTS WITH SMALL CELL-CARCINOMA OF THE LUNG - PRELIMINARY-RESULTS
    MATTSON, K
    NIIRANEN, A
    HOLSTI, LR
    IIVANAINEN, M
    BERGSTROM, L
    STANDERTSKJOLDNORDENSTAM, CG
    TARKKANEN, J
    FARKKILA, M
    ANDERSSON, L
    HOLSTI, P
    KAUPPINEN, HL
    CANTELL, K
    EUROPEAN JOURNAL OF RESPIRATORY DISEASES, 1982, 63 : 41 - 42
  • [23] A 3-day course of 1 mg/kg versus 2 mg/kg bodyweight prednisolone for 1-to 5-year-old children with acute moderate exacerbation of asthma: a randomized double-blind noninferiority trial
    Buddala, Pavan Kumar
    Chandrasekaran, Venkatesh
    Harichandrakumar, K. T.
    PAEDIATRICS & CHILD HEALTH, 2021, 26 (04) : E189 - E193
  • [24] Low-dose Infliximab (3 mg/kg) Significantly Reduces Spinal Inflammation on Magnetic Resonance Imaging in Patients with Ankylosing Spondylitis: A Randomized Placebo-controlled Study
    Maksymowych, Walter P.
    Salonen, David
    Inman, Robert D.
    Rahman, Proton
    Lambert, Robert G. W.
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (08) : 1728 - 1734
  • [25] Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2–3 mg/kg/day): 12-month prospective randomized controlled trial
    Caio B. Zanetti
    Tatiana Pedrosa
    Léonard de V. K. Kupa
    Nadia E. Aikawa
    Eduardo F. Borba
    Margarete B. G. Vendramini
    Clovis A. Silva
    Sandra G. Pasoto
    Eloisa Bonfa
    Clinical Rheumatology, 2021, 40 : 2745 - 2751
  • [26] Hydroxychloroquine blood levels in stable lupus nephritis under low dose (2-3 mg/kg/day): 12-month prospective randomized controlled trial
    Zanetti, Caio B.
    Pedrosa, Tatiana
    Kupa, Leonard de V. K.
    Aikawa, Nadia E.
    Borba, Eduardo F.
    Vendramini, Margarete B. G.
    Silva, Clovis A.
    Pasoto, Sandra G.
    Bonfa, Eloisa
    CLINICAL RHEUMATOLOGY, 2021, 40 (07) : 2745 - 2751
  • [27] Thromboprophylaxis with Fixed Dose, 1mg/Kg/Day, Low Molecular Weight Heparin in Adults Undergoing Induction with Asparaginase for Acute Lymphoblastic Leukemia. Results of a Single Institution Cohort Study
    Al Rabadi, Luai S.
    Olson, Sven Reid
    Shatzel, Joseph J.
    Deloughery, Thomas G.
    Hayes-Lattin, Brandon
    BLOOD, 2017, 130
  • [28] Tildrakizumab provides early predictability of response in patients with moderate to severe psoriasis: Results from reSURFACE 1 and reSURFACE 2 phase 3 trials
    Warren, Richard B.
    Iversen, Lars
    Puig, Luis
    Fumero, Emilio
    Ryzhkova, Anna
    Schoenenberger Lopez, Andreu
    Feldman, Steven R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB10 - AB10
  • [29] Efficacy and safety of an oral fixed low-dose perindopril 2 mg/indapamlde 0.625 mg combination: A randomized, double-blind, placebo-controlled study in elderly patients with mild to moderate hypertension
    Castaigne, A
    Chalmers, J
    Morgan, T
    Chastang, C
    Feldmann, L
    Guez, D
    CLINICAL AND EXPERIMENTAL HYPERTENSION, 1999, 21 (07) : 1097 - 1110
  • [30] Low-Dose Fractionated Radiotherapy Combined with Neoadjuvant Chemotherapy for T3-4 Nasopharyngeal Carcinoma Patients: The Preliminary Results of a Phase II Randomized Controlled Trial
    Feng, M.
    Tang, Y.
    Fan, M.
    Li, L.
    Wang, S.
    Yin, Q.
    Ai, H.
    Zhao, S.
    Yin, Y.
    Liu, D.
    Ren, Y.
    Li, J.
    Li, F.
    Lang, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : E580 - E581